Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.52
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM
8.52
0.00%
Pre-market: Aug 21, 2025, 08:00 AM EDT
Y-mAbs Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.24M | -5.2M | -6.79M | -7M | -9.25M | -6.63M | -988K | -7.75M | -6.3M | -6.39M | 1.16M | -27.53M | -41.13M | -28.07M | -36.89M | -28.86M | -22.94M | 33.41M |
Depreciation & Amortization | 53K | 71K | 102K | 121K | 153K | 159K | 161K | 168K | 224K | 182K | 230K | 226K | 188K | 195K | 291K | 145K | 216K | 130K |
Stock-Based Compensation | 2.9M | 3.34M | 3.08M | 4.2M | 3.44M | 3.85M | 3.12M | 2.5M | 3.62M | 5.3M | 3.54M | 3.34M | 13.63M | 5.09M | 4.91M | 4.9M | 4.83M | 4.7M |
Other Working Capital | -580K | -4.32M | 6.21M | -20.49M | 20.17M | -4K | -7.25M | 5.16M | -3.92M | 1.42M | -8.63M | 1.82M | 5.25M | -1.88M | -4.67M | 991K | 4.13M | 1.3M |
Other Non-Cash Items | -1.94M | -812K | 2.96M | -3.6M | 232K | 492K | 2.44M | 273K | -1.37M | -456K | -121K | 1.97M | 1.42M | 311K | 1.15M | 238K | 78K | -62.01M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -3.33M | n/a | 1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 435K |
Change in Working Capital | 3.88M | -4.32M | -1.22M | -4.38M | 5.72M | -1.34M | -9.44M | 3.47M | -1.95M | -11.76M | -13.46M | 2.76M | 2.79M | -2.45M | -3.31M | 5.5M | -940K | -8.53M |
Operating Cash Flow | 1.65M | -6.91M | -1.87M | -10.66M | 298K | -3.48M | -8.04M | -1.34M | -4.73M | -13.12M | -8.66M | -19.23M | -23.1M | -24.93M | -33.86M | -18.08M | -18.76M | -31.86M |
Capital Expenditures | n/a | -127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -455K | -71K | -41K | -400K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -300K | n/a | n/a | 62.01M |
Investing Cash Flow | n/a | -127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -455K | -71K | -41K | 61.61M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52K | n/a | 32K | 100K | 248K | 131K | 110K |
Financial Cash Flow | 332K | 114K | 986K | 979K | 1.76M | 588K | 100K | n/a | n/a | n/a | n/a | 52K | n/a | 32K | 100K | 248K | 131K | 107.83M |
Net Cash Flow | 1.98M | -6.92M | -888K | -9.68M | 2.06M | -2.89M | -7.93M | -1.34M | -4.72M | -13.13M | -8.76M | -19.14M | -23.06M | -24.84M | -34.17M | -17.86M | -18.68M | 137.64M |
Free Cash Flow | 1.65M | -7.04M | -1.87M | -10.66M | 298K | -3.48M | -8.04M | -1.34M | -4.73M | -13.12M | -8.66M | -19.23M | -23.1M | -24.93M | -34.32M | -18.15M | -18.8M | -32.26M |